LONDON, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Autolus Therapeutics (AUTL) plc , a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, announces the online ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback